Zdrowie i gospodarka · 02/10/2025

FDA Revokes COVID-19 Convalescent Plasma EUA

The US Food and Drug Administration (FDA) has revoked the Emergency Use Authorization (EUA) for COVID-19 convalescent plasma, issued to the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (ASPR/HHS).